Science
Will CRISPR gene therapy expand to 3+ new disease indications by March 31, 2027?
Ends 31 March 2027 · 196 days left · ₦67.8M volume
⚠️ Warning: Insider trading is not permitted. Do not trade on non-public information.
YES contract price
₦573₦ this month
₦67.8M volume
4,012 traders · 196 days left
Order book — YES
Sell orders (asks)
- ₦626,073
- ₦617,211
- ₦604,821
- ₦598,637
- ₦586,930
Buy orders (bids)
- ₦56586
- ₦553,783
- ₦542,748
- ₦534,283
- ₦522,172
About this market
Biotech Innovation: CRISPR therapeutic expansion. Multiple disease targets being pursued.
Resolution rules
Resolves YES if 3+ new CRISPR therapies enter clinical trials or gain approval, or NO if fewer.
Place an order
- Price per contract
- ₦57
- Exchange fee (2%)
- ₦100
- Contracts
- 85.96
- Potential payout
- ₦8,596
- Profit if yes wins
- +₦3,596
Demo trading with virtual naira. Contracts settle at ₦100 if correct, ₦0 if not. Not financial advice — 18+ only.
Exact Score
Predict the exact final score. Click a cell to select, then buy a contract.
₦67.8M traded·4,012 traders
0
1
2
3
4
5
6
7
8
9
10
0
1
2
3
4
5
6
7
8
9
10
Home (left/rows) vs Away (top/columns)